In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Maribavir Drug Master File in Korea (Maribavir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Maribavir. The MFDS reviews the Maribavir KDMF as part of the drug registration process and uses the information provided in the Maribavir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Maribavir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Maribavir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Maribavir suppliers with KDMF on PharmaCompass.